general
Archived signal Translated · English · 2–5m lag
New disappointment in the search for ALS: Novartis has stopped development of experimental medicinal products
Pharmacetic major Novartis has stopped the development of experimental VHB937 for treatment of amyotrophic lateral sclerosis (ALS), one of the most severe advanced neurological diseases.
Reported by 24ur
Read the complete report at 24ur ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
2 reports · 2 sources
24urNew disappointment in the search for ALS: Novartis has stopped development of experimental medicinal products24urNew disappointment in the search for ALS: Novartis has stopped development of experimental medicinal products9 recorded states
Signal first indexedP1 · 68% quality · 1 source
Corroboration 1→2 sources · quality 68→72P1 · 72% quality · 2 sources
Quality 72→76P1 · 76% quality · 2 sources
Quality 76→80P1 · 80% quality · 2 sources
Quality 80→84P1 · 84% quality · 2 sources
Quality 84→88P1 · 88% quality · 2 sources
Quality 88→92P1 · 92% quality · 2 sources
Quality 92→96P1 · 96% quality · 2 sources
Quality 96→99P1 · 99% quality · 2 sources